-+ 0.00%
-+ 0.00%
-+ 0.00%

Tourmaline Bio, QMMM Holdings, Teck Resources And Other Big Stocks Moving Higher On Tuesday

Benzinga·09/09/2025 14:36:32
Listen to the news

U.S. stocks were lower, with the Nasdaq Composite falling around 0.1% on Tuesday.

Shares of Tourmaline Bio, Inc. (NASDAQ:TRML) rose sharply during Tuesday's session after the company announced it entered into an agreement to be acquired by Novartis.

Novartis announced a $1.4 billion acquisition of the U.S.-based biotech, strengthening the Swiss drugmaker's pipeline of cardiovascular and kidney treatments.

Novartis will pay $48.00 per share in cash at closing, a 59% premium to Tourmaline's September 8 closing price and 127% above its 60-day volume-weighted average. The deal is expected to close in the fourth quarter of 2025.

Tourmaline Bio shares jumped 58% to $47.65 on Tuesday.

Here are some other big stocks recording gains in today’s session.

  • QMMM Holdings Limited (NASDAQ:QMMM) gained 42.4% to $16.04 after the company announced it expanded into the cryptocurrency sector.
  • Nebius Group N.V. (NASDAQ:NBIS) gained 37.5% to $88.11 after the company announced it secured up to $19.4 billion 5-year GPU infrastructure contract with Microsoft.
  • Kingsoft Cloud Holdings Limited (NASDAQ:KC) surged 15.8% to $16.36.
  • WhiteFiber, Inc. (NASDAQ:WYFI) rose 15.7% to $18.52.
  • Teck Resources Limited (NYSE:TECK) gained 14% to $40.02 after the company announced a merger of equals with Anglo American.
  • Rezolve AI PLC (NASDAQ:RZLV) rose 13.1% to $5.22.
  • DeFi Development Corp. (NASDAQ:DFDV) gained 12.1% to $16.81.
  • Brighthouse Financial, Inc. (NASDAQ:BHF) rose 10% to $47.71.
  • Cipher Mining Inc. (NASDAQ:CIFR) gained 9.6% to $8.47.
  • Bilibili Inc. (NASDAQ:BILI) rose 8.7% to $24.52.
  • PBF Energy Inc. (NYSE:PBF) gained 8.1% to $30.72.
  • WW International, Inc. (NASDAQ:WW) rose 6.2% to $33.98.
  • Riot Platforms, Inc. (NASDAQ:RIOT) gained 5.6% to $14.20.
  • Alibaba Group Holding Limited (NYSE:BABA) shares climbed 4.2% to $147.15 r after Barclays maintained an Overweight rating on the stock and raised its price target from $145 to $190.

Read This Next:

Photo via Shutterstock